Cycle Pharmaceuticals
Cambridge
About Cycle Pharmaceuticals
Cycle Pharmaceuticals is a pioneering pharmaceutical company, reimagining how drugs can benefit patients, to improve the efficacy of their treatments and their quality of life at every stage. They’re not bound by precedent. Instead, they target overlooked areas of medicine, and market imbalance, where they can make an immediate, tangible difference to patients. By addressing treatment issues with cutting-edge expertise and a fresh, bold approach, they make a difference to patients’ lives.Because their investors are long-term thinkers, they can put patients first. They speak to patients, parents, caregivers, healthcare practitioners and patient associations, to ensure that their needs are central to their work. Whether it’s improving under-developed drugs, or supplying markets where demand is increasing prices and restricting access, they're here to get patients the treatment they need.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $100K – $500K
- Total funding: $25.0M
- Last round: Debt Financing (Sep 2020)
- Website: cyclepharma.com
- Phone: +44 1223 354118
Industries & Categories
Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/cycle-pharmaceuticals-43924 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.